Neuro-Oncology
Journal Abbreviation: NEURO-ONCOLOGY
ISSN: 1522-8517
eISSN: 1523-5866
Publisher: Oxford University Press
Publications (56)
Tumor-associated epilepsy at diagnosis in glioblastoma patients reveals an inflammatory molecular signature and is associated with better overall survival (2026)
Dimova L, Stritzelberger J, Dimov D, Ort J, Hamou HA, Clusmann H, Schnell O, et al.
Journal article
Discrepancies in inter-rater agreement on resectability of recurrent glioblastoma: Complementary post-hoc analysis of the prospective, randomized DIRECTOR trial (2026)
Karschnia P, Teske N, Le Rhun E, Wirsching HG, Jakola AS, Roder C, Cahill DP, et al.
Journal article
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries (2026)
Von Hoff K, Obrecht-Sturm D, Ghasemi DR, Wenning J, Mynarek M, Gerber NU, Benesch M, et al.
Journal article
T cell immunity in glioma and potential implications for immunotherapy: A systematic review (2026)
Luning R, French PJ, Vanbilloen WJ, Dobber L, van Hijfte L, Hoogendijk R, Van den Bent MJ, et al.
Journal article, Review article
Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group (2026)
Teske N, Dono A, Young JS, Jünger ST, Youssef G, Häni L, Sciortino T, et al.
Journal article
Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneity (2026)
Arrieta VA, Benotmane JK, Du R, Habashy KJ, Zhao J, Najem H, Wang S, et al.
Journal article
Early palliative care for patients with glioblastoma: A randomized phase III clinical trial (EPCOG). (2026)
Golla H, Nettekoven C, Hellmich M, Appelmann I, Bausewein C, Becker G, Boehlke C, et al.
Journal article
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients? (2025)
Nozzoli F, Rahmanzade R, Schmid S, Schweizer L, Schrimpf D, Friedel D, Gobel K, et al.
Journal article
Point/counterpoint: The role of re-resection in recurrent glioblastoma (2025)
Young JS, Berger MS, Lasocki A, Suwala AK, Niyazi M, Chang SM, Schnell O, Karschnia P
Journal article
YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas. (2025)
Ali H, Zhou N, Chen L, van Hijfte L, Tulaiha R, Karri V, Zhou Y, et al.
Journal article